• 8373 Citations
  • 33 h-Index
20052020

Research output per year

If you made any changes in Pure these will be visible here soon.

Research Output

2020

Phase 2 study of the focal adhesion kinase inhibitor defactinib (VS-6063) in previously treated advanced KRAS mutant non-small cell lung cancer

Gerber, D. E., Camidge, D. R., Morgensztern, D., Cetnar, J., Kelly, R. J., Ramalingam, S. S., Spigel, D. R., Jeong, W., Scaglioni, P. P., Zhang, S., Li, M., Weaver, D. T., Vaikus, L., Keegan, M., Horobin, J. C. & Burns, T. F., Jan 2020, In : Lung Cancer. 139, p. 60-67 8 p.

Research output: Contribution to journalArticle

1 Scopus citations
2019
6 Scopus citations

Checkpoint Inhibitor Pneumonitis: Too Clinically Serious For Benefit?

Le, T., Minna, J. D. & Gerber, D. E., Mar 1 2019, In : Journal of Thoracic Oncology. 14, 3, p. 332-335 4 p.

Research output: Contribution to journalEditorial

2 Scopus citations

Conceptual model for accrual to cancer clinical trials

Lee, S. C., Murphy, C. C., Geiger, A. M., Gerber, D. E., Cox, J. V., Nair, R. & Skinner, C. S., Aug 10 2019, In : Journal of Clinical Oncology. 37, 23, p. 1993-1996 4 p.

Research output: Contribution to journalComment/debate

1 Scopus citations

Development and Validation of a Nomogram Prognostic Model for Patients With Advanced Non-Small-Cell Lung Cancer

Wang, T., Lu, R., Lai, S., Schiller, J. H., Zhou, F. L., Ci, B., Wang, S., Gao, X., Yao, B., Gerber, D. E., Johnson, D. H., Xiao, G. & Xie, Y., Apr 1 2019, In : Cancer Informatics. 18

Research output: Contribution to journalArticle

Open Access

Hyperprogressive disease: A distinct effect of immunotherapy?

Popat, V. & Gerber, D. E., Jan 1 2019, In : Journal of Thoracic Disease. 11, p. S262-S265

Research output: Contribution to journalReview article

1 Scopus citations

Immunotherapy for non-small cell lung cancer: From clinical trials to real-world practice

Rashdan, S. & Gerber, D. E., Jun 1 2019, In : Translational Lung Cancer Research. 8, 3, p. 202-207 6 p.

Research output: Contribution to journalReview article

Increasing Numbers and Reported Adverse Events in Patients with Lung Cancer Undergoing Inpatient Lung Biopsies: A Population-Based Analysis

von Itzstein, M. S., Gupta, A., Mara, K. C., Khanna, S. & Gerber, D. E., Oct 1 2019, In : Lung. 197, 5, p. 593-599 7 p.

Research output: Contribution to journalArticle

Mobile Device Applications for Electronic Patient Portals in Oncology

Pho, K. K., Lu, R., Gates, S., Cai, J., Xie, D., Xie, Y., Lee, S. C. & Gerber, D. E., Feb 1 2019, In : JCO clinical cancer informatics. 3, p. 1-8 8 p.

Research output: Contribution to journalArticle

1 Scopus citations

Newer-generation EGFR inhibitors in lung cancer: How are they best used?

Le, T. & Gerber, D. E., Mar 1 2019, In : Cancers. 11, 3, 366.

Research output: Contribution to journalReview article

Open Access
7 Scopus citations

NQO1-dependent, tumor-selective radiosensitization of non-small cell lung cancers

Motea, E. A., Huang, X., Singh, N., Kilgore, J. A., Williams, N. S., Xie, X-J., Gerber, D. E., Beg, M. S., Bey, E. A. & Boothman, D. A., Apr 15 2019, In : Clinical Cancer Research. 25, 8, p. 2601-2609 9 p.

Research output: Contribution to journalArticle

2 Scopus citations
1 Scopus citations

Stakeholder engagement to initiate lung cancer screening in an urban safety-net health system

Lee, S. J. C., Hamann, H. A., Browning, T., Santini, N. O., Abbara, S., Balis, D. S., Chiu, H., Moran, B. A., McGuire, M. & Gerber, D. E., Jan 1 2019, (Accepted/In press) In : Healthcare. 100370.

Research output: Contribution to journalArticle

Type and case volume of health care facility influences survival and surgery selection in cases with early-stage non–small cell lung cancer

Wang, S., Lai, S., von Itzstein, M. S., Yang, L., Yang, D. M., Zhan, X., Xiao, G., Halm, E. A., Gerber, D. E. & Xie, Y., Jan 1 2019, (Accepted/In press) In : Cancer.

Research output: Contribution to journalArticle

Unique mutation patterns in anaplastic thyroid cancer identified by comprehensive genomic profiling

Khan, S., Ci, B., Xie, Y., Gerber, D. E., Beg, M. S., Sherman, S. I., Cabanillas, M. E., Busaidy, N. L., Burtness, B. A., Heilmann, A. M., Bailey, M., Ross, J. S., Sher, D. J. & Ali, S. M., Jan 1 2019, In : Head and Neck.

Research output: Contribution to journalArticle

2 Scopus citations

Variation in the Assessment of Immune-Related Adverse Event Occurrence, Grade, and Timing in Patients Receiving Immune Checkpoint Inhibitors

Hsiehchen, D., Watters, M. K., Lu, R., Xie, Y. & Gerber, D. E., Sep 4 2019, In : JAMA network open. 2, 9, p. e1911519

Research output: Contribution to journalArticle

Open Access
2018

Characteristics of patients using patient portals in oncology

Pho, K., Lu, R., Gates, S., Xie, Y., Craddock Lee, S. J. & Gerber, D. E., Mar 1 2018, In : JAMA oncology. 4, 3, p. 416-418 3 p.

Research output: Contribution to journalLetter

1 Scopus citations
157 Scopus citations

Development and Validation of a Nomogram Prognostic Model for SCLC Patients

Wang, S., Yang, L., Ci, B., Maclean, M., Gerber, D. E., Xiao, G. & Xie, Y., Sep 1 2018, In : Journal of Thoracic Oncology. 13, 9, p. 1338-1348 11 p.

Research output: Contribution to journalArticle

4 Scopus citations

Diagnosis and management of pulmonary toxicity associated with cancer immunotherapy

Rashdan, S., Minna, J. D. & Gerber, D. E., Jun 1 2018, In : The Lancet Respiratory Medicine. 6, 6, p. 472-478 7 p.

Research output: Contribution to journalComment/debate

9 Scopus citations

Estimating lead-time bias in lung cancer diagnosis of patients with previous cancers

Ge, Z., Heitjan, D. F., Gerber, D. E., Xuan, L. & Pruitt, S. L., Jan 1 2018, (Accepted/In press) In : Statistics in Medicine.

Research output: Contribution to journalArticle

1 Scopus citations
5 Scopus citations

Immune dysregulation in cancer patients developing immune-related adverse events

Khan, S., Khan, S., Luo, X., Fattah, F. J., Saltarski, J., Gloria-McCutchen, Y., Lu, R., Xie, Y., Li, Q., Wakeland, E. K. & Gerber, D. E., Jan 1 2018, (Accepted/In press) In : British Journal of Cancer.

Research output: Contribution to journalArticle

9 Scopus citations

Main bronchus location is a predictor for metastasis and prognosis in lung adenocarcinoma: A large cohort analysis

Yang, L., Wang, S., Gerber, D. E., Zhou, Y., Xu, F., Liu, J., Liang, H., Xiao, G., Zhou, Q., Gazdar, A. & Xie, Y., Jun 1 2018, In : Lung Cancer. 120, p. 22-26 5 p.

Research output: Contribution to journalArticle

3 Scopus citations

Nivolumab Plus Erlotinib in Patients With EGFR-Mutant Advanced NSCLC

Gettinger, S., Hellmann, M. D., Chow, L. Q. M., Borghaei, H., Antonia, S., Brahmer, J. R., Goldman, J. W., Gerber, D. E., Juergens, R. A., Shepherd, F. A., Laurie, S. A., Young, T. C., Li, X., Geese, W. J. & Rizvi, N., Jan 1 2018, (Accepted/In press) In : Journal of Thoracic Oncology.

Research output: Contribution to journalArticle

23 Scopus citations

Oligometastatic non-small-cell lung cancer: How should we define and manage it?

Gerber, D. E., Jan 1 2018, In : Journal of Oncology Practice. 14, 1, p. 32-34 3 p.

Research output: Contribution to journalComment/debate

Phase 1 study of ARQ 761, a β-lapachone analogue that promotes NQO1-mediated programmed cancer cell necrosis

Gerber, D. E., Beg, M. S., Fattah, F., Frankel, A. E., Fatunde, O., Arriaga, Y., Dowell, J. E., Bisen, A., Leff, R. D., Meek, C. C., Putnam, W. C., Kallem, R. R., Subramaniyan, I., Dong, Y., Bolluyt, J., Sarode, V., Luo, X., Xie, Y., Schwartz, B. & Boothman, D. A., Oct 16 2018, In : British Journal of Cancer. 119, 8, p. 928-936 9 p.

Research output: Contribution to journalArticle

4 Scopus citations
21 Scopus citations

Randomized phase 2 study of tivantinib plus erlotinib versus single-agent chemotherapy in previously treated KRAS mutant advanced non-small cell lung cancer

Gerber, D. E., Socinski, M. A., Neal, J. W., Wakelee, H. A., Shirai, K., Sequist, L. V., Rosovsky, R. P., Lilenbaum, R. C., Bastos, B. R., Huang, C., Johnson, M. L., Hesketh, P. J., Subramaniam, D. S., Dietrich, M. F., Chai, F., Wang, Y., Kazakin, J., Schwartz, B., Schiller, J. H., Brahmer, J. R. & 1 others, Kelly, R. J., Mar 1 2018, In : Lung Cancer. 117, p. 44-49 6 p.

Research output: Contribution to journalArticle

4 Scopus citations

Randomized phase III study of docetaxel plus bavituximab in previously treated advanced non-squamous non-small-cell lung cancer

Gerber, D. E., Horn, L., Boyer, M., Sanborn, R., Natale, R., Palmero, R., Bidoli, P., Bondarenko, I., Germonpre, P., Ghizdavescu, D., Kotsakis, A., Lena, H., Losonczy, G., Park, K., Su, W. C., Tang, M., Lai, J., Kallinteris, N. L., Shan, J. S., Reck, M. & 1 others, Spigel, D. R., Jul 1 2018, In : Annals of Oncology. 29, 7, p. 1548-1553 6 p.

Research output: Contribution to journalArticle

7 Scopus citations

Safety and efficacy of concurrent immune checkpoint inhibitors and hypofractionated body radiotherapy

Mohamad, O., Diaz de Leon, A., Schroeder, S., Leiker, A., Christie, A., Zhang-Velten, E., Trivedi, L., Khan, S., Desai, N. B., Laine, A., Albuquerque, K., Iyengar, P., Arriaga, Y., Courtney, K., Gerber, D. E., Hammers, H., Choy, H., Timmerman, R., Brugarolas, J. & Hannan, R., Mar 10 2018, (Accepted/In press) In : OncoImmunology.

Research output: Contribution to journalArticle

9 Scopus citations

Statistical justification of expansion cohorts in phase 1 cancer trials

Mokdad, A. A., Xie, X. J., Zhu, H., Gerber, D. E. & Heitjan, D. F., Jan 1 2018, (Accepted/In press) In : Cancer.

Research output: Contribution to journalArticle

2 Scopus citations

TNF-driven adaptive response mediates resistance to EGFR inhibition in lung cancer

Gong, K., Guo, G., Gerber, D. E., Gao, B., Peyton, M., Huang, C., Minna, J. D., Hatanpaa, K. J., Kernstine, K., Cai, L., Xie, Y., Zhu, H., Fattah, F. J., Zhang, S., Takahashi, M., Mukherjee, B., Burma, S., Dowell, J., Dao, K., Papadimitrakopoulou, V. A. & 4 others, Olivas, V., Bivona, T. G., Zhao, D. & Habib, A. A., Jun 1 2018, In : Journal of Clinical Investigation. 128, 6, p. 2500-2518 19 p.

Research output: Contribution to journalArticle

14 Scopus citations

ALK alterations and inhibition in lung cancer

Le, T. & Gerber, D. E., Feb 1 2017, In : Seminars in Cancer Biology. 42, p. 81-88 8 p.

Research output: Contribution to journalReview article

12 Scopus citations

A phase ib dose-escalation study of the safety, tolerability, and pharmacokinetics of cobimetinib and duligotuzumab in patients with previously treated locally advanced ormetastatic cancers with mutant KRAS

Lieu, C. H., Hidalgo, M., Berlin, J. D., Ko, A. H., Cervantes, A., LoRusso, P., Gerber, D. E., Paul Eder, J., Gail Eckhardt, S., Kapp, A. V., Tsuhako, A., McCall, B., Pirzkall, A., Uyei, A. & Tabernero, J., Sep 1 2017, In : Oncologist. 22, 9

Research output: Contribution to journalArticle

8 Scopus citations

Cancer center clinic and research team perceptions of identity and interactions

Reimer, T., Lee, S. J. C., Garcia, S., Gill, M., Duncan, T., Williams, E. L. & Gerber, D. E., Dec 1 2017, In : Journal of Oncology Practice. 13, 12, p. e1021-e1029

Research output: Contribution to journalArticle

3 Scopus citations

Histologic transformation of EGFR mutant lung adenocarcinoma without exposure to EGFR inhibition

Le, T., Sailors, J., Oliver, D. H., Mayer, M., Hoskin, S. & Gerber, D. E., Mar 1 2017, In : Lung Cancer. 105, p. 14-16 3 p.

Research output: Contribution to journalArticle

7 Scopus citations

Institutional scientific review of cancer clinical research protocols: A unique requirement that affects activation timelines

Ning, N., Yan, J., Dietrich, M. F., Xie, X. J. & Gerber, D. E., Dec 1 2017, In : Journal of Oncology Practice. 13, 12, p. e982-e991

Research output: Contribution to journalReview article

Nivolumab plus ipilimumab as first-line treatment for advanced non-small-cell lung cancer (CheckMate 012): results of an open-label, phase 1, multicohort study

Hellmann, M. D., Rizvi, N. A., Goldman, J. W., Gettinger, S. N., Borghaei, H., Brahmer, J. R., Ready, N. E., Gerber, D. E., Chow, L. Q., Juergens, R. A., Shepherd, F. A., Laurie, S. A., Geese, W. J., Agrawal, S., Young, T. C., Li, X. & Antonia, S. J., Jan 1 2017, In : The Lancet Oncology. 18, 1, p. 31-41 11 p.

Research output: Contribution to journalArticle

410 Scopus citations

Oncology nursing perceptions of patient electronic portal use: A qualitative analysis

Gerber, D. E., Beg, M. S., Duncan, T., Gill, M. & Lee, S. J. C., Mar 1 2017, In : Oncology Nursing Forum. 44, 2, p. 165-170 6 p.

Research output: Contribution to journalArticle

1 Scopus citations

Patient navigation for lung cancer screening in an urban safety-net system: Protocol for a pragmatic randomized clinical trial

Gerber, D. E., Hamann, H. A., Santini, N. O., Abbara, S., Chiu, H., McGuire, M., Quirk, L., Zhu, H. & Lee, S. J. C., Sep 1 2017, In : Contemporary Clinical Trials. 60, p. 78-85 8 p.

Research output: Contribution to journalArticle

6 Scopus citations

Phase 2 study of intermittent pulse dacomitinib in patients with advanced non-small cell lung cancers

Yu, H. A., Ahn, M. J., Cho, B. C., Gerber, D. E., Natale, R. B., Socinski, M. A., Giri, N., Quinn, S., Sbar, E., Zhang, H. & Giaccone, G., Oct 1 2017, In : Lung Cancer. 112, p. 195-199 5 p.

Research output: Contribution to journalArticle

5 Scopus citations

Phase II study of olaratumab with paclitaxel/carboplatin (P/C) or P/C alone in previously untreated advanced NSCLC

Gerber, D. E., Swanson, P., Lopez-Chavez, A., Wong, L., Dowlati, A., Pennell, N. A., Cronier, D. M., Qin, A., Ilaria, R., Cosaert, J., Shahir, A. & Baggstrom, M. Q., Sep 1 2017, In : Lung Cancer. 111, p. 108-115 8 p.

Research output: Contribution to journalArticle

6 Scopus citations

Revisiting a longstanding clinical trial exclusion criterion: impact of prior cancer in early-stage lung cancer

Pruitt, S. L., Laccetti, A. L., Xuan, L., Halm, E. A. & Gerber, D. E., Feb 14 2017, (Accepted/In press) In : British Journal of Cancer.

Research output: Contribution to journalArticle

19 Scopus citations

Therapeutic Targeting of Nuclear Export Inhibition in Lung Cancer

Gupta, A., Saltarski, J. M., White, M. A., Scaglioni, P. P. & Gerber, D. E., Sep 1 2017, In : Journal of Thoracic Oncology. 12, 9, p. 1446-1450 5 p.

Research output: Contribution to journalArticle

6 Scopus citations

Thoracic Oncology Clinical Trial Eligibility Criteria and Requirements Continue to Increase in Number and Complexity

Garcia, S., Bisen, A., Yan, J., Xie, X. J., Ramalingam, S., Schiller, J. H., Johnson, D. H. & Gerber, D. E., Oct 1 2017, In : Journal of Thoracic Oncology. 12, 10, p. 1489-1495 7 p.

Research output: Contribution to journalArticle

12 Scopus citations

Time and Effort Required for Tissue Acquisition and Submission in Lung Cancer Clinical Trials

Garcia, S., Saltarski, J. M., Yan, J., Xie, X. J. & Gerber, D. E., Feb 28 2017, (Accepted/In press) In : Clinical Lung Cancer.

Research output: Contribution to journalArticle

5 Scopus citations
2 Scopus citations